added structure for part 2
This commit is contained in:
parent
048d10e7dd
commit
b6d3c8e69c
@ -5,6 +5,9 @@
|
||||
\save_transient_properties true
|
||||
\origin unavailable
|
||||
\textclass article
|
||||
\begin_preamble
|
||||
\rfoot{6420013}
|
||||
\end_preamble
|
||||
\use_default_options true
|
||||
\maintain_unincluded_children false
|
||||
\language english
|
||||
@ -73,7 +76,7 @@
|
||||
\dynamic_quotes 0
|
||||
\papercolumns 1
|
||||
\papersides 1
|
||||
\paperpagestyle default
|
||||
\paperpagestyle fancy
|
||||
\tracking_changes false
|
||||
\output_changes false
|
||||
\html_math_output 0
|
||||
@ -1042,7 +1045,7 @@ name "tab:Effective-masses"
|
||||
|
||||
\begin_layout Standard
|
||||
As the electrical and optical properties of the valence band are governed
|
||||
by the heavy hole interactions, this effective mass ration will be used.
|
||||
by the heavy hole interactions, this effective mass ratio will be used.
|
||||
\end_layout
|
||||
|
||||
\begin_layout Standard
|
||||
@ -1747,8 +1750,8 @@ Conclusions
|
||||
Considering these two probabilities it is clear that it is more likely for
|
||||
the electron to be found between 6nm and 8nm than between 2nm and 4nm across
|
||||
the well.
|
||||
This is as expected as 6nm to 8nm places the interval towards the center
|
||||
of the well.
|
||||
This is as expected considering 6nm to 8nm places the interval towards
|
||||
the center of the well.
|
||||
As the probability density function is a
|
||||
\begin_inset Formula $\sin^{2}$
|
||||
\end_inset
|
||||
@ -1766,7 +1769,7 @@ noprefix "false"
|
||||
|
||||
this can be seen graphically as the region created by the purple lines
|
||||
has a far greater area under the probability density function than the
|
||||
region between the green lines.
|
||||
region formed by the green lines.
|
||||
\end_layout
|
||||
|
||||
\begin_layout Standard
|
||||
@ -1781,7 +1784,26 @@ Application of Nanomaterials
|
||||
\end_layout
|
||||
|
||||
\begin_layout Standard
|
||||
Word count:
|
||||
The use of albumin protein nanoparticlces has provided a new delivery method
|
||||
for the highly effective chemotherapy drug, paclitaxel, in turn reducing
|
||||
side effects caused by previous delivery schemes and increasing circulation
|
||||
half life around the body.
|
||||
\end_layout
|
||||
|
||||
\begin_layout Section
|
||||
Paclitaxel
|
||||
\end_layout
|
||||
|
||||
\begin_layout Section
|
||||
Previous Delivery
|
||||
\end_layout
|
||||
|
||||
\begin_layout Section
|
||||
Albumin
|
||||
\end_layout
|
||||
|
||||
\begin_layout Section
|
||||
NAB-Paclitaxel
|
||||
\end_layout
|
||||
|
||||
\begin_layout Standard
|
||||
|
BIN
coursework.pdf
BIN
coursework.pdf
Binary file not shown.
Loading…
Reference in New Issue
Block a user